{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:23:57Z","timestamp":1785860637023,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016694","name":"Science and Technology Development Plan of Shandong Province","doi-asserted-by":"publisher","award":["2013GSF11902"],"award-info":[{"award-number":["2013GSF11902"]}],"id":[{"id":"10.13039\/100016694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573945"],"award-info":[{"award-number":["81573945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH054"],"award-info":[{"award-number":["ZR2021MH054"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112581","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T20:08:35Z","timestamp":1719605315000},"page":"112581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway"],"prefix":"10.1016","volume":"138","author":[{"given":"Wenfei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-8155","authenticated-orcid":false,"given":"Fengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112581_b0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep4.1906","article-title":"Effect of Omega-3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome and NAFLD","volume":"6","author":"\u0160m\u00edd","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.intimp.2024.112581_b0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2024.112581_b0015","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.intimp.2024.112581_b0020","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00391.2020","article-title":"Deconstructing organs: single-cell analyses, decellularized organs, organoids, and organ-on-a-chip models: holistic characterization of single-hepatocyte transcriptome responses to high-fat diet","volume":"320","author":"Park","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2024.112581_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.787143","article-title":"Oral-gut microbiome analysis in patients with metabolic-associated fatty liver disease having different tongue image feature","volume":"12","author":"Lu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2024.112581_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-022-03201-7","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model","volume":"13","author":"Shi","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2024.112581_b0035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2024.112581_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100889","article-title":"The NLRP3 inflammasome: mechanism of action, role in disease and therapies","volume":"76","author":"Wang","year":"2020","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.intimp.2024.112581_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112581_b0050","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2024.112581_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.613639","article-title":"TLR9 in MAFLD and NASH: at the intersection of inflammation and metabolism","volume":"11","author":"Shepard","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2024.112581_b0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210809119","article-title":"The Gasdermin D N-terminal fragment acts as a negative feedback system to inhibit inflammasome-mediated activation of Caspase-1\/11","volume":"119","author":"Hu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2024.112581_b0065","series-title":"Obesity, Fatty Liver and Liver Cancer","first-page":"19","article-title":"Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease","author":"Farrell","year":"2018"},{"key":"10.1016\/j.intimp.2024.112581_b0070","article-title":"Research progress of pyroptosis in fatty liver disease","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112581_b0075","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation and fibrosis","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.112581_b0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2024.112581_b0085","doi-asserted-by":"crossref","DOI":"10.7150\/thno.49603","article-title":"Statins ameliorate cholesterol-induced inflammation and improve AQP2 expression by inhibiting NLRP3 activation in the kidney","volume":"10","author":"Kong","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2024.112581_b0090","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2147\/DDDT.S368836","article-title":"Diosgenin and its analogs: potential protective agents against atherosclerosis","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2024.112581_b0095","article-title":"Dioscorea spp.: bioactive compounds and potential for the treatment of inflammatory and metabolic diseases","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112581_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.xplc.2020.100079","article-title":"The origin and evolution of the diosgenin biosynthetic pathway in yam","volume":"2","author":"Cheng","year":"2021","journal-title":"Plant Commun."},{"key":"10.1016\/j.intimp.2024.112581_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114018","article-title":"Dioscin and diosgenin: insights into their potential protective effects in cardiac diseases","volume":"274","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.112581_b0110","first-page":"514","article-title":"Diosgenin and 4-hydroxyisoleucine from fenugreek are regulators of genes involved in lipid metabolism in the human colorectal cancer cell line SW480","volume":"22","author":"Mohammad-Sadeghipour","year":"2021","journal-title":"Cell J."},{"key":"10.1016\/j.intimp.2024.112581_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/1035441","article-title":"Diosgenin: an updated pharmacological review and therapeutic perspectives","volume":"2022","author":"Semwal","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2024.112581_b0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-014-2152-x","article-title":"Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPAR\u03b3 activity in type 2 diabetic rats","volume":"396","author":"Tharaheswari","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2024.112581_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155299","article-title":"Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway","volume":"125","author":"Yan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.112581_b0130","first-page":"1124","article-title":"Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8","volume":"2019","author":"Li","year":"1864","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.intimp.2024.112581_b0135","article-title":"Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112581_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175808","article-title":"Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C\/PPAR\u03b1\/CD36 pathway","volume":"952","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112581_b0145","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2024.112581_b0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-015-0220-7","article-title":"Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma","volume":"8","author":"Lou","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2024.112581_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04735-7","article-title":"Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease","volume":"13","author":"Pang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112581_b0160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.112581_b0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12072-017-9838-6","article-title":"Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis","volume":"12","author":"Oseini","year":"2018","journal-title":"Hep. Intl."},{"key":"10.1016\/j.intimp.2024.112581_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.112581_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2024.112581_b0180","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus: a bidirectional relationship","volume":"2020","author":"Muzica","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2024.112581_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106925","article-title":"Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development","volume":"196","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.112581_b0190","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2174\/1874467215666211217120448","article-title":"Potential natural compounds for the prevention and treatment of non-alcoholic fatty liver disease: a review on molecular mechanisms","volume":"15","author":"Ma","year":"2022","journal-title":"CMP"},{"key":"10.1016\/j.intimp.2024.112581_b0195","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3390\/ijms23052764","article-title":"Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates","volume":"23","author":"Salvoza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112581_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106621","article-title":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","volume":"187","author":"Yan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.112581_b0205","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112581_b0210","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112581_b0215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.32320","article-title":"Nlrp3 activation causes spontaneous inflammation and fibrosis that mimics human NASH","volume":"76","author":"Calcagno","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.112581_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091475","article-title":"Mitochondria and the NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis","volume":"11","author":"Torres","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112581_b0225","article-title":"Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112581_b0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2024.112581_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609060","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112581_b0240","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2024.112581_b0245","doi-asserted-by":"crossref","unstructured":"Q. Ma, Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction, 2023.","DOI":"10.1124\/pharmrev.122.000629"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:57:25Z","timestamp":1778619445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924011020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"alternative-id":["S1567576924011020"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112581","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112581"}}